mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for PTPRB
Gene summary
Basic gene Info.Gene symbolPTPRB
Gene nameprotein tyrosine phosphatase, receptor type, B
SynonymsHPTP-BETA|HPTPB|PTPB|R-PTP-BETA|VEPTP
CytomapUCSC genome browser: 12q15-q21
Type of geneprotein-coding
RefGenesNM_001109754.2,
NM_001206971.1,NM_001206972.1,NM_002837.4,
DescriptionVE-PTPprotein tyrosine phosphatase, receptor type, beta polypeptidereceptor-type tyrosine-protein phosphatase betavascular endothelial protein tyrosine phosphatase
Modification date20141207
dbXrefs MIM : 176882
HGNC : HGNC
Ensembl : ENSG00000127329
HPRD : 01474
Vega : OTTHUMG00000169499
ProteinUniProt: P23467
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_PTPRB
BioGPS: 5787
PathwayNCI Pathway Interaction Database: PTPRB
KEGG: PTPRB
REACTOME: PTPRB
Pathway Commons: PTPRB
ContextiHOP: PTPRB
ligand binding site mutation search in PubMed: PTPRB
UCL Cancer Institute: PTPRB
Assigned class in mutLBSgeneDBB: This gene belongs to targetable_mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0016311dephosphorylation19116766


Top
Ligand binding site mutations for PTPRB
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
R1715V1713MBRCA1
G1907G1907VHNSC1
R1910T1911NLUSC1
R1715V1713MUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for PTPRB
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
G1907G1907V-1.0676127
R1715V1713M-0.88935205
R1910T1911N-0.42682541
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for PTPRB from PDB

Top
Differential gene expression and gene-gene network for PTPRB
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of PTPRB and the right PPI network was created from samples without mutations in the LBS of PTPRB. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for PTPRB
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0018923Hemangiosarcoma1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for PTPRB
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
ExperimentalDB06989{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACIDSmall molecule
ExperimentalDB07068(4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACIDSmall molecule
ExperimentalDB07127{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACIDSmall molecule
ExperimentalDB08678(4-ETHYLPHENYL)SULFAMIC ACIDSmall molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of PTPRB go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
4UN{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID2h04AG1907 R1910
UA1N-(TERT-BUTOXYCARBONYL)-L-TYROSYL-N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE2i4gAR1715 R1910
2UN[4-(2-BENZYL-3-METHOXY-2-METHOXYCARBONYL-3-OXOPROPYL)PHENYL]SULFAMIC ACID2h02AR1910
2UN[4-(2-BENZYL-3-METHOXY-2-METHOXYCARBONYL-3-OXOPROPYL)PHENYL]SULFAMIC ACID2h02BR1910
3UN(4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID2h03AR1910
UA1N-(TERT-BUTOXYCARBONYL)-L-TYROSYL-N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE2i4hAR1910
UA5(4-ETHYLPHENYL)SULFAMIC ACID2i5xAR1910
UA5(4-ETHYLPHENYL)SULFAMIC ACID2i5xBR1910


Top
Conservation information for LBS of PTPRB
Multiple alignments for P23467 in multiple species
LBSAA sequence# speciesSpecies
A1906VVHCSAGVGRT2Homo sapiens, Mus musculus
A1906VVHCSAGVGRS1Drosophila melanogaster
C1904PTVVHCSAGVG2Homo sapiens, Mus musculus
C1904PIVVHCSAGVG1Drosophila melanogaster
D1870YTVWPDHGVPE2Homo sapiens, Mus musculus
D1870FTTWPDFGVPN1Drosophila melanogaster
G1907VHCSAGVGRTG2Homo sapiens, Mus musculus
G1907VHCSAGVGRSG1Drosophila melanogaster
G1909CSAGVGRTGTF2Homo sapiens, Mus musculus
G1909CSAGVGRSGTF1Drosophila melanogaster
H1871TVWPDHGVPET2Homo sapiens, Mus musculus
H1871TTWPDFGVPNP1Drosophila melanogaster
H1945RLHRVHMVQTE2Homo sapiens, Mus musculus
H1945RKERVWMVQTE1Drosophila melanogaster
I1736NRYNNILPYDA2Homo sapiens, Mus musculus
I1736NRFTNILPYDH1Drosophila melanogaster
K1811EKGRVKCDHYW2Homo sapiens, Mus musculus
K1811EKGREKCDQYW1Drosophila melanogaster
N1734GKNRYNNILPY2Homo sapiens, Mus musculus
N1734PKNRFTNILPY1Drosophila melanogaster
N1735KNRYNNILPYD2Homo sapiens, Mus musculus
N1735KNRFTNILPYD1Drosophila melanogaster
Q1948RVHMVQTECQY2Homo sapiens, Mus musculus
Q1948RVWMVQTEQQY1Drosophila melanogaster
R1715LKDVGRNQSCD1Homo sapiens
R1715LKHVGRDQPCT1Drosophila melanogaster
R1715LKDVGRSQSCD1Mus musculus
R1732NRGKNRYNNIL2Homo sapiens, Mus musculus
R1732NRPKNRFTNIL1Drosophila melanogaster
R1809CVEKGRVKCDH2Homo sapiens, Mus musculus
R1809CFEKGREKCDQ1Drosophila melanogaster
R1910SAGVGRTGTFI1Homo sapiens
R1910SAGVGRSGTFI1Drosophila melanogaster
R1910SAGVGRTGTFV1Mus musculus
S1905TVVHCSAGVGR2Homo sapiens, Mus musculus
S1905IVVHCSAGVGR1Drosophila melanogaster
V1908HCSAGVGRTGT2Homo sapiens, Mus musculus
V1908HCSAGVGRSGT1Drosophila melanogaster
Y1733RGKNRYNNILP2Homo sapiens, Mus musculus
Y1733RPKNRFTNILP1Drosophila melanogaster


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas